- ISIN
- US5713541093
- CUSIP
- 571354109
- Sector
- Healthcare
- Industry
- Healthcare Plans
- IPO Date
- Oct 27, 2021
Highlights
- Market Cap
- $44.05M
- Enterprise Value
- $44.85M
- EPS (TTM)
- -$0.79
- Total Revenue (TTM)
- $17.13M
- Gross Profit (TTM)
- $3.99M
- EBITDA (TTM)
- -$13.28M
- Year Range
- $0.22 - $2.50
- Target Price
- $6.00
- ROA (TTM)
- -152.76%
- ROE (TTM)
- 47.31%
- Avg. Volume (1M)
- 143K
- Avg. Volume Value (1M)
- $248.62K
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
MRAI Performance Chart
Marpai, Inc. (MRAI) is up 253.4% since the beginning of the year. At $2 per share, MRAI is trading 10.8% below its 52-week high of $3.
Loading charts...
Compare this symbol against anything
Returns By Period
Marpai, Inc. (MRAI) has returned 253.41% so far this year and 88.98% over the past 12 months.
Marpai, Inc.
- 1D
- 0.90%
- 1M
- 209.72%
- 6M
- 182.89%
- YTD
- 253.41%
- 1Y
- 88.98%
- 3Y*
- 6.23%
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- -35.16%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
MRAI Monthly Returns History
Based on dividend-adjusted daily data since Oct 27, 2021, MRAI's average daily return is +0.30%, while the average monthly return is +8.09%. At this rate, an investment would double in approximately 0.7 years.
Historically, 47% of months were positive and 53% were negative. The best month was Nov 2023 with a return of +412.2%, while the worst month was May 2024 at -68.5%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 7 months.
On a daily basis, MRAI closed higher 46% of trading days. The best single day was Apr 13, 2023 with a return of +90.3%, while the worst single day was May 28, 2024 at -53.6%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 24.93% | -28.83% | -48.31% | -6.90% | 177.04% | 6.28% | 180.50% | 253.41% | |||||
| 2025 | 5.26% | -9.00% | 12.09% | -1.96% | 39.50% | -3.23% | -2.96% | 7.63% | -3.55% | 6.62% | -31.03% | -36.90% | -33.58% |
| 2024 | -30.29% | 17.21% | 70.63% | -16.80% | -68.45% | 6.16% | -23.51% | 5.75% | 0.91% | 69.37% | 70.21% | -40.63% | -45.71% |
| 2023 | 27.68% | 5.52% | 2.99% | -34.62% | 9.89% | -40.43% | 4.09% | -50.56% | -24.89% | -39.15% | 412.18% | -15.05% | -39.24% |
| 2022 | -47.03% | -13.79% | -10.00% | -11.11% | -23.75% | -20.74% | -16.37% | 16.08% | 10.79% | -15.38% | 10.53% | -25.98% | -83.56% |
| 2021 | 27.85% | -31.43% | 14.06% | 0.00% |
Benchmark Metrics
Marpai, Inc. has an annualized alpha of 83.83%, beta of 1.22, and R2 of 0.02 versus S&P 500 Index. Calculated based on daily prices since October 27, 2021.
- This stock participated in 240.78% of S&P 500 Index downside but only 115.64% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.02 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 83.83%
- Beta
- 1.22
- R²
- 0.02
- Upside Capture
- 115.64%
- Downside Capture
- 240.78%
Return for Risk
Risk / Return Rank
MRAI ranks 68 for risk / return — above 68% of stocks peers on PortfoliosLab. Its historical combined result is above most peers.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for Marpai, Inc. (MRAI) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MRAI | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.02 | ||
| Sortino ratioReturn per unit of downside risk | 0.00 | ||
| Omega ratioGain probability vs. loss probability | 1.25 | 1.25 | -0.01 |
| Calmar ratioReturn relative to maximum drawdown | 0.82 | 2.00 | -1.18 |
| Martin ratioReturn relative to average drawdown | 1.29 | 8.49 | -7.21 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Marpai, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Marpai, Inc. was 99.02%, occurring on May 13, 2026. The portfolio has not yet recovered.
The current Marpai, Inc. drawdown is 90.22%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-99.02%May 2026 | 4y 6mo | — | 4y 9moOct 2021 - now | — |
Drawdown Indicators
| MRAI | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.02% | -56.78% | -42.24% |
Max Drawdown (1Y)Largest decline over 1 year | -86.25% | -9.10% | -77.15% |
Max Drawdown (3Y)Largest decline over 3 years | -92.07% | -18.90% | -73.17% |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -90.22% | -1.58% | -88.64% |
Average DrawdownAverage peak-to-trough decline | -87.26% | -10.70% | -76.56% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 54.76% | 2.14% | +52.62% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Marpai, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Marpai, Inc. is priced in the market compared to other companies in the Healthcare Plans industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for MRAI relative to other companies in the Healthcare Plans industry. Currently, MRAI has a P/S ratio of 2.7. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with MRAI
Add Marpai, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with MRAI